Skip to main content
Equibles
KYNB logo

KYNB · Kyntra Bio, Inc. · Metrics

Track KYNB — free

Use KYNB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KYNB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.28 +0.00 (+0.00%) At close · Oct 20
Rebalance outlook locked
Market Cap
$21.38M
Shares
4.05M
Volume · Oct 20 13.55K Avg daily vol (3M) 19.56K

KYNB metrics

80 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$5.28
Market cap
$21.38M

Price action

20 metrics
Price change (1W)
-10.1%
Price change (30D)
-26.7%
Price change (3M)
-27.7%
Price change (6M)
-25.2%
Price change (YTD)
-39.9%
Price change (1Y)
-52.6%
Trailing year
Price change (5Y)
—
52-week high
$11.18
52-week low
$4.85
Change from 52-week high
-52.8%
Change from 52-week low
+8.9%
Annualized volatility
53.3%
Annualized volatility (3M)
48.3%
Beta
1.1
RSI (14D)
29.8
Price vs SMA 50
-25.2%
Price vs SMA 200
-27.5%
Avg volume (3M)
19,555
Relative volume
0.7
Average dollar volume
$137,221

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
4.05M

Valuation

12 metrics
P / E (TTM)
0.1
Trailing earnings · reciprocal yield 858.0%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
4.6×
reciprocal yield 21.6%
P / book
—
FCF yield
-178.0%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
856.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
6.3%
Operating margin
-1,089.8%
Trailing 12 months
Net margin
3,967.8%
Gross profit (TTM)
$290,000
Operating profit (TTM)
−$50.31M
Net income (TTM)
$183.19M
Trailing 12 months
Diluted EPS (TTM)
$45.30
FCF margin
-824.4%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$1.14
Gross profit per diluted share (TTM)
$0.07
Operating profit per diluted share (TTM)
$-12.43
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$45.30
Operating cash flow per diluted share (TTM)
$-9.40
Free cash flow per diluted share (TTM)
$-9.40
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
$5.65
Stock compensation per diluted share (TTM)
$0.98
Book value per share
$-7.42

Growth

11 metrics
Revenue growth YoY
-209.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$4.62M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.1%
Year over year · more shares
Revenue CAGR (3Y)
-64.2%
Revenue CAGR (5Y)
-48.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
181.2%
Debt / equity
—
Current ratio
2.7
EBITDA (TTM)
—
Free cash flow (TTM)
−$38.06M
Quick ratio
2.6
Interest coverage
-5.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$50.64M
Total assets
$101.08M
Total debt
$75.00M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$38.05M
Capital expenditures (TTM)
$9,000
R&D (TTM)
$22.86M
SG&A (TTM)
$27.67M
Stock compensation (TTM)
$3.99M
R&D / revenue
495.2%
Stock compensation / revenue
86.3%

Ownership (13F)

9 metrics
13F filers
28
13F filer change QoQ
-5
Institutional ownership
26.9%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
13.0%
Private-fund adviser ownership
12.9%
Active holders' share change QoQ
-5.2%
Holder tenure
4.3
Price vs estimated holder cost
+0.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
4.8%

Short interest

3 metrics
Short interest
2.5%
Latest settlement · 3.7 days to cover
Days to cover
3.7d
Short-squeeze score
39 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 921299 CUSIP 31572Q881 13F (30d) 1 filings 1 filers Visit website Investor relations